Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor–Positive Breast Cancer

Characterization of immune subpopulations could help refine the prognostic value of TILs in young patients with HR-positive breast cancer, who may benefit from risk stratification for treatment individualization.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-10-21
DOI
https://doi.org/10.1158/1078-0432.ccr-25-0948
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor–Positive Breast Cancer

Virginia F. Borges, Jeffrey M. Peppercorn, Yujing Jan Heng, Shoshana M. Rosenberg et al.
1 citations
Clinical Cancer Research
Cancer Immunotherapy and Biomarkers
1.05
article

Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor–Positive Breast Cancer

Virginia F. Borges, Jeffrey M. Peppercorn, Yujing Jan Heng, Shoshana M. Rosenberg, Laura C. Collins, Craig Snow, Yaileen D. Guzmán‐Arocho, Kathryn J. Ruddy, Elizabeth A. Mittendorf, Lidia Schapira, Ann H. Partridge, Rulla M. Tamimi, Steven E. Come, Nabihah Tayob, Megan E. Tesch, Eric P. Winer, Yue Zheng
article en
1 citations

Abstract

Characterization of immune subpopulations could help refine the prognostic value of TILs in young patients with HR-positive breast cancer, who may benefit from risk stratification for treatment individualization.

Clinical Cancer Research
Brigham and Women's Hospital (US), Beth Israel Deaconess Medical Center (US), Cancer Prevention Institute of California (US), Mayo Clinic (US), Harvard University (US), Cornell University (US), Beth Israel Deaconess Hospital (US), Harvard University Press (US), Yale Cancer Center (US), Massachusetts General Hospital (US), Dana-Farber Cancer Institute (US), Mayo Clinic in Arizona (US), University of Colorado Cancer Center (US), Dana-Farber/Harvard Cancer Center (US), Dana-Farber Brigham Cancer Center (US), Weill Cornell Medicine (US), University of Colorado Denver (US), Stanford University (US)
Openalex Percentile: Top 17%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.